October 2006
Kilkenny Capital Management: Biomedical long/short fund profits from US healthcare mispricings
Michael Walsh of hedge fund Kilkenny Capital Management talks to Helen Avery about the fund’s melding of information about medical innovators’ development and sales processes with finance theory to assess biotechs’ future value.
Michael Walsh is a biochemist with training in corporate finance from working at Robertson Stephens and Drexel Burnham Lambert. So he is in a very good position to be running a biomedical hedge fund. For the past 11 years he has been doing just that at Kilkenny Capital Management.
Kilkenny manages a long/short biomedical fund following more than 250 companies in the high-margin biomedical space. It’s a good market to be in. According to Walsh, the number of biotech companies has tripled in the past 10 to 20 years. Healthcare spending in the US now accounts for 16% of GDP, and about 10% of this expenditure is in the innovative biomedical sector. Demographics in the US suggest that there will be further growth in the area. “Most healthcare costs occur in the later years of a person’s life,” says Walsh. “Healthcare spending in the next few years will become a...
You must be a Level 2 subscriber to access this archived content.
If your subscription includes access to the archive, please log in now to view.
To gain access to this content visit the subscription page or call our hotline on +44 (0)207 779 8999.
Subscribe online now and save up to 30% on your subscription.
If you are a trialist or subscriber, please enter your username and password at the top right-hand side of euromoney.com
Subscribers to Euromoney benefit from:
Level 1:
- Online access to the past 12 months content
- Tailored RSS news feeds direct to your desktop
- News delivered directly to your mobile device or PC
- Personalised email newsfeed of 'Top stories' and 'Breaking news'
Level 2:
- Exclusive access to euromoney.com - Read the latest issue early online, search for specific developments by region or sector, interrogate the results of Euromoney's benchmark polls, and view the archive dating back to 2000
- 12 monthly issues of Euromoney magazine
- More than 30 specialist research guides free
- The results of Euromoney’s polls and surveys
- Tailored RSS news feeds direct to your desktop
- News delivered directly to your mobile device or PC
- Personalised email newsfeed of 'Top stories' and 'Breaking news'
Click here to subscribe